venBio Select Advisor

Latest statistics and disclosures from Avoro Capital Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Avoro Capital Advisors

Avoro Capital Advisors holds 42 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apellis Pharmaceuticals Common (APLS) 9.2 $665M 11M 59.86
 View chart
United Therapeutics Corp Common (UTHR) 8.7 $629M 2.9M 219.89
 View chart
Ascendis Pharma Sponsored ADR (ASND) 6.5 $473M +2% 3.8M 125.95
 View chart
Argenx Se Sponsored ADR (ARGX) 6.5 $470M +23% 1.2M 380.43
 View chart
Madrigal Pharmaceuticals Common (MDGL) 6.0 $437M +21% 1.9M 231.38
 View chart
Sarepta Therapeutics Common (SRPT) 5.8 $419M +7% 4.3M 96.43
 View chart
Biomarin Pharmaceutical Common (BMRN) 5.7 $415M +11% 4.3M 96.42
 View chart
Spdr Series Trust - S&p Biotech Etf (XBI) 5.5 $397M NEW 4.4M 89.29
 View chart
Amicus Therapeutics Common (FOLD) 5.4 $389M 27M 14.19
 View chart
Cerevel Therapeutics Hldng Common (CERE) 4.4 $320M +690% 7.6M 42.40
 View chart
Krystal Biotech Common (KRYS) 4.4 $318M 2.6M 124.06
 View chart
Mirati Therapeutics Common (MRTX) 4.0 $287M -26% 4.9M 58.75
 View chart
Cymabay Therapeutics Common (CBAY) 3.6 $262M +7% 11M 23.62
 View chart
Xenon Pharmaceuticals Common (XENE) 3.6 $261M +15% 5.7M 46.06
 View chart
Alnylam Pharmaceuticals Common (ALNY) 2.9 $213M +9% 1.1M 191.41
 View chart
Intra-cellular Therapies Common (ITCI) 2.2 $162M NEW 2.3M 71.62
 View chart
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.2 $156M +29% 2.6M 60.39
 View chart
Kymera Therapeutics Common (KYMR) 1.3 $96M -2% 3.8M 25.46
 View chart
Structure Therapeutics Sponsored ADR (GPCR) 1.3 $95M +133% 2.3M 40.76
 View chart
Syndax Pharmaceuticals Common (SNDX) 1.3 $91M +65% 4.2M 21.61
 View chart
Biocryst Pharmaceuticals Common (BCRX) 1.1 $78M +12% 13M 5.99
 View chart
Iovance Biotherapeutics Common (IOVA) 0.8 $55M 6.7M 8.13
 View chart
Roivant Sciences Common (ROIV) 0.7 $52M 4.7M 11.23
 View chart
Kura Oncology Common (KURA) 0.6 $43M 3.0M 14.38
 View chart
Spyre Therapeutics Common (SYRE) 0.5 $40M +15951% 1.8M 21.52
 View chart
Karuna Therapeutics Common (KRTX) 0.5 $40M NEW 125k 316.51
 View chart
Rocket Pharmaceuticals Common (RCKT) 0.5 $38M 1.3M 29.97
 View chart
Arrowhead Pharmaceuticals Common (ARWR) 0.5 $35M +100% 1.1M 30.60
 View chart
Marinus Pharmaceuticals Common (MRNS) 0.5 $34M 3.2M 10.87
 View chart
Mannkind Corp Common (MNKD) 0.5 $33M 9.0M 3.64
 View chart
Soleno Therapeutics Common (SLNO) 0.4 $32M NEW 785k 40.25
 View chart
Verrica Pharmaceuticals Common (VRCA) 0.4 $29M +35% 4.0M 7.32
 View chart
Immunogen Common (IMGN) 0.4 $26M NEW 875k 29.65
 View chart
Monte Rosa Therapeutics Common (GLUE) 0.4 $26M 4.5M 5.65
 View chart
Merus N V Common (MRUS) 0.3 $24M +100% 889k 27.50
 View chart
Tourmaline Bio Common 0.3 $23M NEW 868k 26.18
 View chart
Avidity Biosciences Common (RNA) 0.3 $23M 2.5M 9.05
 View chart
Ultragenyx Pharmaceutical Common (RARE) 0.2 $17M -76% 350k 47.82
 View chart
Fennec Pharmaceuticals Common (FENC) 0.2 $14M 1.2M 11.22
 View chart
Nuvalent Common (NUVL) 0.2 $13M -77% 179k 73.59
 View chart
Taysha Gene Therapies Common (TSHA) 0.1 $7.7M +10% 4.4M 1.77
 View chart
Aadi Biosciences Common (AADI) 0.1 $5.8M 2.8M 2.02
 View chart

Past Filings by Avoro Capital Advisors

SEC 13F filings are viewable for Avoro Capital Advisors going back to 2014

View all past filings